Tempest Therapeutics, Inc. (TPST) is a biotechnology company focused on the development of small molecule therapeutics that modulate anti-tumor immunity. The latest closing stock price for Tempest Therapeutics as of September 06, is · The all-time high Tempest Therapeutics stock closing price was. TPST / Tempest Therapeutics, Inc. (NasdaqCM) - Forecast, Price Target, Estimates, Predictions. Tempest Therapeutics is developing first-in-class small molecule product candidates with broad potential benefit to patients. Tempest Therapeutics (TPST) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.
On average, Wall Street analysts predict that Tempest Therapeutics's share price could reach $ by Aug 15, The average Tempest Therapeutics stock. Find out all the key statistics for Tempest Therapeutics, Inc. (TPST), including valuation measures, fiscal year financial statistics, trading record. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Tempest merged with Millendo on 6/28/ Tempest Therapeutics Inc ; May PM · Tempest to Present at the Jefferies Global Healthcare Conference. (GlobeNewswire) % % ; May PM. On Tuesday 09/03/ the closing price of the Tempest Therapeutics Inc Registered Shs share was $ on BTT. Compared to the opening price on Tuesday 09/03/. Tempest Therapeutics Inc. ; High, $ ; Median, $ ; Low, $ ; Average, $ ; Current Price, $ Tempest Therapeutics Inc TPST:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date10/11/23 · 52 Week Low Tempest Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development and discovery of small molecule drugs for the treatment. Tempest Therapeutics, Inc. (my8.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Tempest Therapeutics. Discover real-time Tempest Therapeutics, Inc. Common Stock (TPST) stock prices, quotes, historical data, news, and Insights for informed trading and. On Tuesday 09/03/ the closing price of the Tempest Therapeutics Inc Registered Shs share was $ on BTT. Compared to the opening price on Tuesday 09/03/.
Stock analysis for Tempest Therapeutics Inc (TPST:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. TPST | Complete Tempest Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The current price of TPST is USD — it has decreased by −% in the past 24 hours. Watch Tempest Therapeutics, Inc. stock price performance more closely. See TPST stock price and Buy/Sell Tempest Therapeutics. Discuss news and analysts' price predictions with the investor community. Tempest Therapeutics Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Tempest Therapeutics Stock (NASDAQ: TPST) stock price, news, charts, stock research, profile. The Investor Relations website contains information about Tempest Therapeutics's business for stockholders, potential investors, and financial analysts. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Get the latest Tempest Therapeutics Inc (TPST) real-time quote, historical performance, charts, and other financial information to help you make more.
The average price target for Tempest Therapeutics, Inc. comes to $ The forecasts range from a low of $ to a high of $ 49 minutes ago. Track Tempest Therapeutics Inc (TPST) Stock Price, Quote, latest community messages, chart, news and other stock related information. For the upcoming trading day on Monday, 9th we expect Tempest Therapeutics Inc. to open at $, and during the day (based on 14 day Average True Range), to. Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of.
Get real-time updates on Tempest Therapeutics, Inc. Common Stock (TPST) stock quotes, trades, and more. Make informed investments with Nasdaq. Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the. BRISBANE, Calif., Sept. 05, (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing. Tempest Therapeutics Shares Are Trading Lower. The Company Announced Data From the Ongoing Global Randomized Phase 1b/2 Clinical Study for Amezalpat2. Tempest. Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated. Get Tempest Therapeutics Inc (3OS-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. Latest Tempest Therapeutics Inc (3OS:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and. Tempest Therapeutics Inc. · AT CLOSE PM EDT 08/30/24 · USD · % · Volume,
Can You Transfer Southwest Points To Another Airline | What Is The Best $1000 Investment